Trial to Evaluate Cardiovascular and Other Long-term Outcomes With Semaglutide in Subjects With Type 2 Diabetes
Clinical trial NCT01720446 · COMPLETED
Trial details
- NCT number
- NCT01720446
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-02-21
- Primary completion
- 2016-03-15
- Enrollment
- 3297
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.